相似文献
1
Helicobacter pylori: tailored therapy with novel sequential quadruple therapies.
Nat Rev Gastroenterol Hepatol. 2013 Jan;10(1):6-8. doi: 10.1038/nrgastro.2012.232. Epub 2012 Nov 27.
2
Ten-day Quadruple therapy comprising proton-pump inhibitor, bismuth, tetracycline, and levofloxacin achieves a high eradication rate for Helicobacter pylori infection after failure of sequential therapy.
Helicobacter. 2014 Feb;19(1):74-9. doi: 10.1111/hel.12085. Epub 2013 Sep 6.
3
Pylera and sequential therapy for first-line Helicobacter pylori eradication: a culture-based study in real clinical practice.
Eur J Gastroenterol Hepatol. 2018 Jun;30(6):621-625. doi: 10.1097/MEG.0000000000001102.
4
Concomitant, sequential, and hybrid therapy for Helicobacter pylori: which one is the correct answer?
Clin Res Hepatol Gastroenterol. 2013 Dec;37(6):e125-6. doi: 10.1016/j.clinre.2013.07.007. Epub 2013 Aug 24.
5
Sequential therapy for Helicobacter pylori: time to consider making the switch?
JAMA. 2008 Sep 17;300(11):1346-7. doi: 10.1001/jama.300.11.1346.
6
[Acid-related diseases. What is the current rescue treatment of choice for Helicobacter pylori: quadruple therapy (proton pump inhibitor, bismuth, tetracycline and metronidazole) or triple therapy with proton pump inhibitor, amoxicillin and levofloxacin?].
Gastroenterol Hepatol. 2008 Jun-Jul;31(6):400-1. doi: 10.1157/13123612.
7
Equivalent Efficacies of Reverse Hybrid and Bismuth Quadruple Therapies in Eradication of Helicobacter pylori Infection in a Randomized Controlled Trial.
Clin Gastroenterol Hepatol. 2018 Sep;16(9):1427-1433. doi: 10.1016/j.cgh.2018.03.031. Epub 2018 Mar 31.
8
Modified sequential therapy vs quadruple therapy as initial therapy in patients with Helicobacter infection.
World J Gastroenterol. 2015 May 28;21(20):6310-6. doi: 10.3748/wjg.v21.i20.6310.
9
Comparison Between Sequential Therapy and Modified Bismuth-Included Quadruple Therapy for Helicobacter pylori Eradication in Chinese Patients.
Am J Ther. 2016 Nov/Dec;23(6):e1436-e1441. doi: 10.1097/MJT.0000000000000261.
10
Comparative Effect of Proton-Pump Inhibitors on the Success of Triple and Quadruple Therapy for Helicobacter pylori Infection.
Dig Dis. 2020;38(5):408-414. doi: 10.1159/000504909. Epub 2020 Jan 7.
引用本文的文献
1
Comparison of the efficacy and safety of hybrid and sequential therapies as a first-line regimen for infection in Turkey.
Arch Med Sci. 2018 Mar;14(2):276-280. doi: 10.5114/aoms.2016.58595. Epub 2016 Mar 16.
2
Rational Helicobacter pylori therapy: evidence-based medicine rather than medicine-based evidence.
Clin Gastroenterol Hepatol. 2014 Feb;12(2):177-86.e3; Discussion e12-3. doi: 10.1016/j.cgh.2013.05.028. Epub 2013 Jun 8.
本文引用的文献
1
Helicobacter pylori eradication in Western Australia using novel quadruple therapy combinations.
Aliment Pharmacol Ther. 2012 Dec;36(11-12):1076-83. doi: 10.1111/apt.12089. Epub 2012 Oct 16.
2
Efficacy of a modified sequential therapy including bismuth subcitrate as first-line therapy to eradicate Helicobacter pylori in a Turkish population.
Helicobacter. 2012 Dec;17(6):486-90. doi: 10.1111/j.1523-5378.2012.00989.x. Epub 2012 Aug 26.
3
Efficacy of 5-day levofloxacin-containing concomitant therapy in eradication of Helicobacter pylori infection.
Gastroenterology. 2012 Jul;143(1):55-61.e1; quize e13-4. doi: 10.1053/j.gastro.2012.03.043. Epub 2012 Apr 3.
4
Furazolidone in Helicobacter pylori therapy: misunderstood and often unfairly maligned drug told in a story of French bread.
Saudi J Gastroenterol. 2012 Jan-Feb;18(1):1-2. doi: 10.4103/1319-3767.91724.
5
Modified sequential Helicobacter pylori therapy: proton pump inhibitor and amoxicillin for 14 days with clarithromycin and metronidazole added as a quadruple (hybrid) therapy for the final 7 days.
Helicobacter. 2011 Apr;16(2):139-45. doi: 10.1111/j.1523-5378.2011.00828.x.
6
Optimal therapy for Helicobacter pylori infections.
Nat Rev Gastroenterol Hepatol. 2011 Feb;8(2):79-88. doi: 10.1038/nrgastro.2010.210.
7
Levofloxacin-based triple therapy versus bismuth-based quadruple therapy for persistent Helicobacter pylori infection: a meta-analysis.
Am J Gastroenterol. 2006 Mar;101(3):488-96. doi: 10.1111/j.1572-0241.2006.00637.x.
8
Efficacy and safety of rifabutin-containing 'rescue therapy' for resistant Helicobacter pylori infection.
Aliment Pharmacol Ther. 2006 Feb 15;23(4):481-8. doi: 10.1111/j.1365-2036.2006.02793.x.
9
Systematic review and meta-analysis: levofloxacin-based rescue regimens after Helicobacter pylori treatment failure.
Aliment Pharmacol Ther. 2006 Jan 1;23(1):35-44. doi: 10.1111/j.1365-2036.2006.02737.x.
10
Meta-analysis: the efficacy, adverse events, and adherence related to first-line anti-Helicobacter pylori quadruple therapies.
Aliment Pharmacol Ther. 2004 Nov 15;20(10):1071-82. doi: 10.1111/j.1365-2036.2004.02248.x.
Zotero 插件